EMS BIOFILM DISCLOSER
Overview
The EMS BIOFILM DISCLOSER is a specially formulated diagnostic aid developed for Guided Biofilm Therapy (GBT). Designed to visibly differentiate early and mature biofilm, this two-tone disclosing solution enhances treatment accuracy, improves patient communication, and streamlines the cleaning process using AIRFLOW® PLUS Powder.
Key Highlights
Two-Tone Biofilm Disclosing Pellets
- Red color indicates new biofilm
- Blue color highlights mature biofilm
Clear Visual Aid
Makes biofilm instantly visible to both the practitioner and the patient for targeted and effective treatment.
Improves Clinical Efficiency
Identifying biofilm helps direct AIRFLOW® treatment more effectively, allowing quicker and more thorough cleaning.
Supports Patient Education & Motivation
Patients can see their biofilm buildup and better understand the need for treatment and regular hygiene.
Ideal for Use with AIRFLOW® PLUS Powder
Enhances removal by clearly indicating problematic zones—once biofilm is removed, calculus is easier to detect.
Product Details
Component | Details |
Pellets per Bottle | 250 pre-soaked disclosing pellets |
Color-Coding | Red = new biofilm, Blue = mature biofilm |
Usage | For visual diagnosis in GBT |
Product Code | DV-158 |
Watch the Video
Clients Testimonials
Playlist
1:13
2:08
0:55
FAQ's
It uses a two-tone color system to distinguish between early and mature biofilm, helping tailor the treatment accordingly.
Yes, it is designed to complement AIRFLOW® PLUS Powder in the Guided Biofilm Therapy protocol.
Absolutely! Visual evidence increases patient motivation and compliance with preventive treatments.
Disclaimer:
Product configurations, features, and specifications are subject to change based on the original manufacturer’s design and supply. Certain accessories or attachments may not be included in the standard offering and can vary by model or production batch. We recommend confirming all required features at the time of purchase. Requests for additions post-delivery will be considered based on availability and feasibility, and may incur additional costs.